$20.0B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | INCY Incyte Corp | 30.8M | +0.1% | $3.5B | 17.5% |
| 2 | ONC Beone Medicines Ltd | 8.8M | +0.0% | $2.5B | 12.6% |
| 3 | RVMD Revolution Medicines Inc | 11.4M | +19.8% | $2.1B | 10.7% |
| 4 | MDGL Madrigal Pharmaceuticals Inc | 2.1M | +0.1% | $1.2B | 5.8% |
| 5 | ACAD Acadia Pharmaceuticals Inc | 42.9M | +0.0% | $1.1B | 5.4% |
| 6 | KYMR Kymera Therapeutics Inc | 8.7M | +0.0% | $993M | 5.0% |
| 7 | INSM Insmed Inc | 8.8M | +18.5% | $938M | 4.7% |
| 8 | CELC Celcuity Inc | 7.9M | +0.0% | $828M | 4.2% |
| 9 | KOD Kodiak Sciences Inc | 19.9M | +0.0% | $776M | 3.9% |
| 10 | RYTM Rhythm Pharmaceuticals Inc | 5.6M | +0.0% | $622M | 3.1% |
| 11 | PRAX Praxis Precision Medicines I | 1.8M | +0.0% | $587M | 2.9% |
| 12 | ALKS Alkermes Plc | 10.0M | +0.0% | $525M | 2.6% |
| 13 | SMMT Summit Therapeutics Inc | 32.8M | −9.9% | $478M | 2.4% |
| 14 | GRAL Grail Inc | 4.0M | +0.0% | $275M | 1.4% |
| 15 | ABCL Abcellera Biologics Inc | 33.0M | +9.0% | $259M | 1.3% |
| 16 | IMVT Immunovant Inc | 5.4M | −0.4% | $209M | 1.0% |
| 17 | IDYA Ideaya Biosciences Inc | 5.0M | +26.9% | $187M | 0.9% |
| 18 | KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl | 2.8M | +0.3% | $181M | 0.9% |
| 19 | ROIV Roivant Sciences Ltd | 4.7M | −3.1% | $167M | 0.8% |
| 20 | ARWR Arrowhead Pharmaceuticals In | 2.0M | +0.0% | $162M | 0.8% |
| 21 | IONS Ionis Pharmaceuticals Inc | 2.0M | +0.0% | $162M | 0.8% |
| 22 | EWTX Edgewise Therapeutics Inc | 3.7M | −43.7% | $150M | 0.8% |
| 23 | REPL Replimune Group Inc | 11.0M | +0.0% | $122M | 0.6% |
| 24 | NRIX Nurix Therapeutics Inc | 4.7M | +0.0% | $113M | 0.6% |
| 25 | STOK Stoke Therapeutics Inc | 3.3M | +0.0% | $109M | 0.5% |
| 26 | GLUE Monte Rosa Therapeutics Inc | 4.3M | +0.0% | $105M | 0.5% |
| 27 | IMTX Immatics N.V | 9.5M | −12.9% | $96M | 0.5% |
| 28 | DNLI Denali Therapeutics Inc | 3.7M | +0.1% | $96M | 0.5% |
| 29 | CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In | 2.4M | +0.0% | $88M | 0.4% |
| 30 | DNTH Dianthus Therapeutics Inc | 852,164 | +0.0% | $83M | 0.4% |
| 31 | GPCR Structure Therapeutics Inc | 1.4M | +0.0% | $77M | 0.4% |
| 32 | RAPP Rapport Therapeutics Inc | 1.5M | +0.0% | $64M | 0.3% |
| 33 | ALMS Alumis Inc | 2.0M | +0.0% | $57M | 0.3% |
| 34 | PRLD Prelude Therapeutics Inc | 10.1M | +0.0% | $54M | 0.3% |
| 35 | RLAY Relay Therapeutics Inc | 2.8M | +143.7% | $53M | 0.3% |
| 36 | MIRM Mirum Pharmaceuticals Inc | 445,975 | +0.0% | $52M | 0.3% |
| 37 | BCYC Bicycle Therapeutics Plc | 10.9M | +0.0% | $46M | 0.2% |
| 38 | ELVN Enliven Therapeutics Inc | 905,191 | +0.0% | $46M | 0.2% |
| 39 | CLDX Celldex Therapeutics Inc New | 1.2M | +77.7% | $44M | 0.2% |
| 40 | VRDN Viridian Therapeutics Inc | 2.4M | +20.9% | $44M | 0.2% |
| 41 | DSGN Design Therapeutics Inc | 2.7M | +3.6% | $39M | 0.2% |
| 42 | TRDA Entrada Therapeutics Inc | 5.1M | +0.0% | $37M | 0.2% |
| 43 | FTH Faeth Therapeutics Inc | 1.3M | — | $32M | 0.2% |
| 44 | AKTS Aktis Oncology Inc | 996,351 | +0.0% | $32M | 0.2% |
| 45 | NGNE Neurogene Inc | 991,691 | +0.0% | $31M | 0.2% |
| 46 | JBIO Jade Biosciences Inc | 1.2M | −25.0% | $27M | 0.1% |
| 47 | TSHA Taysha Gene Therapies Inc | 4.0M | +0.0% | $27M | 0.1% |
| 48 | RCUS Arcus Biosciences Inc | 844,816 | +103.3% | $26M | 0.1% |
| 49 | IRON Disc Medicine Inc | 349,657 | +0.0% | $26M | 0.1% |
| 50 | ABSI Absci Corporation | 2.1M | +0.0% | $25M | 0.1% |